HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition
Phase 3
Withdrawn
- Conditions
- Diarrhea, MalnutritionOther Nutritional Deficiencies
- Registration Number
- NCT00133562
- Lead Sponsor
- University of Virginia
- Brief Summary
This study will determine the effect of 7 days supplementation of alanyl-glutatime or glycine on the damaged intestinal barrier function on day 8 in children with persistent diarrhea or malnutrition.
- Detailed Description
The purpose of this study is to determine the effect of 7 days supplementation of alanyl-glutamine or glycine on the damaged intestinal barrier function, measured by lactulose/mannitol test on day 8, in children with persistent diarrhea or malnutrition; on diarrhea frequency and duration, weight gain, protein loss, intestinal inflammation, and lactoferrin excretion.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- 108
Inclusion Criteria
- Children ages 3 to 36 months with a history of persistent diarrhea (3 or more unformed stools/day) for >2 weeks or height-for-age Z-score (HAZ) less than negative 1, which is the median of HAZ score in children at HIAS.
- Be an inpatient and willing to stay for 7 nights at HIAS.
- Child´s parent or guardian must sign informed consent..
Read More
Exclusion Criteria
- Children exclusively breast-fed (Reason: The diet needs to be controlled in order to evaluate the study treatment effect)
- Children who participated in the community study or any other study within the past two years (Reason: The children in the community study will have received glutamine.)
- Children with suspected other illnesses as indicated by fever >102º F at time of screening off antipyretics
- Children with suspected systemic disease at the time of screening including but not limited to shock, meningitis, sepsis, pneumonia, tuberculosis, varicella
- Severe malnutrition defined as HAZ <-3 or WAZ <-3.5 or any child weighing <10 lbs. (4.5 kg) or any child with a weight-to-height ratio <60% of the NCHS age adjusted norm.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method